ViGenCell Inc
308080
Company Profile
Business description
ViGenCell Inc specializes in immune cell therapy products. The companies various immune cell therapies has contributed to prolonged life expectancy and much enhanced quality of life for patients suffering from incurable diseases.
Contact
66 Gasan-ro 9-gil
9th floor, Therizen Valley Knowledge Industry Center
Seoul06591
KORT: +82 27850201
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
52
Stocks News & Analysis
stocks
Going into earnings, is Netflix stock a buy, a sell, or fairly valued?
Watching sales growth and the potential for margin expansion, here’s what we think of Netflix stock.
stocks
Bapcor is paying for the sins of its past
Shares plunged over 17% after reporting disappointing results.
stocks
Overvalued ASX share as market underestimates downside risks
Growth outlook solid, but upside more than priced in.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,401.00 | 27.30 | 0.29% |
| CAC 40 | 8,206.07 | 31.87 | 0.39% |
| DAX 40 | 24,258.80 | 427.81 | 1.80% |
| Dow JONES (US) | 46,706.58 | 515.97 | 1.12% |
| FTSE 100 | 9,403.57 | 49.00 | 0.52% |
| HKSE | 26,206.17 | 347.34 | 1.34% |
| NASDAQ | 22,990.54 | 310.57 | 1.37% |
| Nikkei 225 | 49,835.43 | 649.93 | 1.32% |
| NZX 50 Index | 13,334.06 | 10.90 | -0.08% |
| S&P 500 | 6,735.13 | 71.12 | 1.07% |
| S&P/ASX 200 | 9,103.00 | 27.10 | 0.30% |
| SSE Composite Index | 3,879.92 | 16.02 | 0.41% |